Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Difficulties in the prevention, diagnosis, and treatment of imported malaria.
|
Arch Intern Med
|
2000
|
2.17
|
2
|
Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum.
|
J Biol Chem
|
2000
|
2.16
|
3
|
Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3.
|
Biochem J
|
2001
|
2.00
|
4
|
The proteases and pathogenicity of parasitic protozoa.
|
Annu Rev Microbiol
|
1993
|
1.96
|
5
|
Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
|
Clin Pharmacol Ther
|
2012
|
1.87
|
6
|
Structure-based inhibitor design by using protein models for the development of antiparasitic agents.
|
Proc Natl Acad Sci U S A
|
1993
|
1.82
|
7
|
Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda.
|
J Infect Dis
|
2001
|
1.75
|
8
|
Killing of Neisseria meningitidis by human neutrophils: implications for normal and complement-deficient individuals.
|
J Infect Dis
|
1987
|
1.65
|
9
|
Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial.
|
Lancet
|
2001
|
1.58
|
10
|
The comparative efficacy of chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Kampala, Uganda.
|
Trans R Soc Trop Med Hyg
|
2001
|
1.45
|
11
|
Comparison of efficacies of cysteine protease inhibitors against five strains of Plasmodium falciparum.
|
Antimicrob Agents Chemother
|
2001
|
1.40
|
12
|
Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: implications for malaria treatment in Africa.
|
Clin Pharmacol Ther
|
2007
|
1.39
|
13
|
Antimalarial effects in mice of orally administered peptidyl cysteine protease inhibitors.
|
Bioorg Med Chem
|
1999
|
1.34
|
14
|
Systematic optimization of expression and refolding of the Plasmodium falciparum cysteine protease falcipain-2.
|
Protein Expr Purif
|
2001
|
1.32
|
15
|
Identification of three stage-specific proteinases of Plasmodium falciparum.
|
J Exp Med
|
1987
|
1.30
|
16
|
Synthesis of quinolinyl chalcones and evaluation of their antimalarial activity.
|
Eur J Med Chem
|
2001
|
1.28
|
17
|
Antimalarial synergy of cysteine and aspartic protease inhibitors.
|
Antimicrob Agents Chemother
|
1998
|
1.27
|
18
|
Functional expression of falcipain, a Plasmodium falciparum cysteine proteinase, supports its role as a malarial hemoglobinase.
|
Infect Immun
|
1995
|
1.17
|
19
|
Predictors of chloroquine treatment failure in children and adults with falciparum malaria in Kampala, Uganda.
|
Am J Trop Med Hyg
|
2000
|
1.17
|
20
|
Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors.
|
Bioorg Med Chem
|
1998
|
1.10
|
21
|
Recombinant falcipain-2 cleaves erythrocyte membrane ankyrin and protein 4.1.
|
Mol Biochem Parasitol
|
2001
|
1.09
|
22
|
Cysteine proteinase inhibitors block early steps in hemoglobin degradation by cultured malaria parasites.
|
Blood
|
1996
|
0.96
|
23
|
Light effects in yeast: persisting oscillations in cell division activity and amino acid transport in cultures of Saccharomyces cerevisiae entrained by light-dark cycles.
|
Photochem Photobiol
|
1979
|
0.92
|
24
|
Plasmodial serine repeat antigen homologues with properties of schizont cysteine proteases.
|
Mol Biochem Parasitol
|
1998
|
0.88
|
25
|
Intermittent preventive therapy for malaria in pregnancy: is sulfadoxine-pyrimethamine the right drug?
|
Clin Pharmacol Ther
|
2010
|
0.87
|
26
|
The impact of whole genome sequence data on drug discovery--a malaria case study.
|
Mol Med
|
2001
|
0.87
|
27
|
Antiprotozoal activities of some constituents of Markhamia tomentosa (Bignoniaceae).
|
Ann Trop Med Parasitol
|
2010
|
0.87
|
28
|
Anti-malarial drug development using models of enzyme structure.
|
Chem Biol
|
1994
|
0.84
|
29
|
Synthesis and antimalarial effects of phenothiazine inhibitors of a Plasmodium falciparum cysteine protease.
|
J Med Chem
|
1997
|
0.82
|
30
|
Light effects in yeast: evidence for participation of cytochromes in photoinhibition of growth and transport in Saccharomyces cerevisiae cultured at low temperatures.
|
J Bacteriol
|
1979
|
0.81
|
31
|
Drug overdoses with antimalarial agents: prescribing and dispensing errors.
|
JAMA
|
1998
|
0.78
|
32
|
Availability of intravenous quinidine for falciparum malaria.
|
N Engl J Med
|
1996
|
0.77
|
33
|
Protective immune responses against protease-like antigens of the murine malaria parasite Plasmodium vinckei.
|
Vaccine
|
1998
|
0.77
|
34
|
Malaria in a Trinidadian man.
|
N Engl J Med
|
2000
|
0.75
|
35
|
Humoral immune responses of Africans to cysteine protease-related antigens of Plasmodium falciparum.
|
J Infect Dis
|
1998
|
0.75
|